| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapy
|
Gnant, M.
|
|
2009
|
18 |
S1 |
p. S53-
1 p.
|
artikel
|
| 2 |
0025 A comparative study of immunohistochemical staining and fluorescence in situ hybridization method of HER-2/neu in breast cancer
|
Koo, M.
|
|
2009
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 3 |
0215 Adenexal mass in patients with prior breast carcinoma
|
Samizadeh Nikoy Tabalvandani, Z.
|
|
2009
|
18 |
S1 |
p. S72-
1 p.
|
artikel
|
| 4 |
0002 Adiponectin differentially affects gene expression in human mammary epithelial cells and breast cancer cells
|
Lattrich, C.R.
|
|
2009
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 5 |
0151 Adjuvant dose-dense adriamycin plus cytoxan followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: A pilot study
|
Pippen, J.
|
|
2009
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 6 |
0245 Analysis of clinical information related to breast cancer from a hospital information system and the generation of a new document for recalling clinical information
|
Hwang, K.
|
|
2009
|
18 |
S1 |
p. S79-
1 p.
|
artikel
|
| 7 |
0055 Analysis of HER-2/neu extracellular domain in serum from breast cancer patients: Correlation with clinicopathologic parameters and prognostic significance
|
Vrbanec, D.
|
|
2009
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 8 |
0011 Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
|
Boneberg, E.M.
|
|
2009
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 9 |
0014 Antitumor effect of experimental soybean feeding depends on estrogen-sensitivity of tumors
|
Zaletok, S.P.
|
|
2009
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 10 |
0174 A phase III study of adjuvant endocrine therapy with or without chemotherapy for postmenopausal breast cancer patients who responded to neoadjuvant letrozole: Study design of the new primary endocrine-therapy origination study [NEOS (N-SAS BC06)]
|
Iwata, H.
|
|
2009
|
18 |
S1 |
p. S62-
1 p.
|
artikel
|
| 11 |
0118 A preliminary report of a phase I study of intraoperative radiotherapy (IORT) for early breast cancer in Japan
|
Sawaki, M.
|
|
2009
|
18 |
S1 |
p. S48-S49
2 p.
|
artikel
|
| 12 |
0092 A prospective clinical study for molecular intra-operative detection of lymph node metastasis in breast cancer patients by “one step nucleic acid amplification (OSNA)” in comparison with intensive histological investigation
|
Buglioni, S.
|
|
2009
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 13 |
0244 A quality initiative: Guideline compliance in postmenopausal women with stage IB-IIIC early breast cancer receiving adjuvant hormonal therapy
|
Bosserman, L.
|
|
2009
|
18 |
S1 |
p. S79-
1 p.
|
artikel
|
| 14 |
0137 Aromatase inhibitors: Questions remaining to be answered
|
Monnier, A.M.
|
|
2009
|
18 |
S1 |
p. S53-
1 p.
|
artikel
|
| 15 |
0133 A survey of oncologists on the duration of adjuvant aromatase inhibitor therapy - factors that influence treatment decisions in early breast cancer
|
Citron, M.L.
|
|
2009
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 16 |
Author Index
|
|
|
2009
|
18 |
S1 |
p. S81-S86
6 p.
|
artikel
|
| 17 |
0120 A weekly fractionated radiotherapy regimen for brain metastases in breast cancer patients with poor performance status
|
Munshi, A.
|
|
2009
|
18 |
S1 |
p. S49-
1 p.
|
artikel
|
| 18 |
0090 Axillary staging of breast cancer with the sentinel lymph node (SLN) procedure in over a thousand patients with early breast cancer
|
Persyn, F.
|
|
2009
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 19 |
0049 αB crystallin as a novel marker of lymph node metastasis in breast cancer
|
Kim, L.
|
|
2009
|
18 |
S1 |
p. S30-
1 p.
|
artikel
|
| 20 |
0223 Bilateral breast carcinoma - synchronous and metachronous lesion - a retrospective analysis from a tertiary center in South India
|
Selvan, B.
|
|
2009
|
18 |
S1 |
p. S74-
1 p.
|
artikel
|
| 21 |
0026 Bioptical method: A major predictor of adherence after benign breast biopsy?
|
Zagouri, F.
|
|
2009
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 22 |
0032 Breast cancer and sarcoidosis: Case series and review of the literature
|
Chen, J.
|
|
2009
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 23 |
0222 Breast cancer in an Asian population: Are there racial differences?
|
Seah, J.
|
|
2009
|
18 |
S1 |
p. S74-
1 p.
|
artikel
|
| 24 |
0219 Breast cancer in “elderly” women
|
De Matías Martínez, M.
|
|
2009
|
18 |
S1 |
p. S73-
1 p.
|
artikel
|
| 25 |
0247 Breast cancer in Kenyan women
|
Nyabade, G.O.
|
|
2009
|
18 |
S1 |
p. S79-S80
2 p.
|
artikel
|
| 26 |
0218 Breast cancer in the elderly: Does the management of those over 75 years differ from those under 75?
|
Noguero Meseguer, M.
|
|
2009
|
18 |
S1 |
p. S73-
1 p.
|
artikel
|
| 27 |
0094 Breast cancer prediction models for non sentinel axillary lymph node metastases - assessing validity and correlation to disease recurrence
|
Baruch, E.
|
|
2009
|
18 |
S1 |
p. S42-
1 p.
|
artikel
|
| 28 |
0225 Breast carcinoma in Jewish and non-Jewish population
|
Rabkin, A.
|
|
2009
|
18 |
S1 |
p. S74-S75
2 p.
|
artikel
|
| 29 |
0119 Breast seroma after intraoperative radiotherapy with low-kV x-rays
|
Kraus-Tiefenbacher, U.
|
|
2009
|
18 |
S1 |
p. S49-
1 p.
|
artikel
|
| 30 |
0134 CARIATIDE study: Evaluation of the impact of educational material on the compliance and persistence rates to adjuvant aromatase inhibitor (AI) medication for postmenopausal women with hormone sensitive early breast cancer
|
Neven, P.
|
|
2009
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 31 |
0034 Chemopreventive effect of green tea extract and tamoxifen on mouse mammary preneoplastic lesions
|
Sakata, M.
|
|
2009
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 32 |
0146 Chronobiological rhythms of cytokines level of breast cancer
|
Melnikov, D.Y.
|
|
2009
|
18 |
S1 |
p. S55-S56
2 p.
|
artikel
|
| 33 |
0060 Circulating tumor cells in early breast cancer - multimarker analysis
|
de Albuquerque, A.
|
|
2009
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 34 |
0213 Clinical characteristics of triple negative breast cancers
|
Hur, M.
|
|
2009
|
18 |
S1 |
p. S71-
1 p.
|
artikel
|
| 35 |
0184 Clinical experience with fulvestrant, pure oestrogen receptor (ER) antagonist with no agonist effects, in pre-treated advanced breast cancer patients
|
Menjón, S.S.M.
|
|
2009
|
18 |
S1 |
p. S65-
1 p.
|
artikel
|
| 36 |
0236 Clinicopathologic features of microinvasive cancer compared with DCIS
|
Min, S.
|
|
2009
|
18 |
S1 |
p. S77-S78
2 p.
|
artikel
|
| 37 |
0141 Combination of antagonists of growth hormone-releasing hormone with docetaxel as potential therapy in breast cancer in a preclinical study
|
Seitz, S.
|
|
2009
|
18 |
S1 |
p. S54-
1 p.
|
artikel
|
| 38 |
0020 Comparison of cytologic findings of nipple discharge with galactographic findings
|
Matkovic, V.
|
|
2009
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 39 |
0063 Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients (PATH) with early stage breast cancer
|
Kunz, G.
|
|
2009
|
18 |
S1 |
p. S34-
1 p.
|
artikel
|
| 40 |
0182 Concomitant radio-chemotherapy (RCT) in inflammatory breast cancer (IBC) non responsive to primary chemotherapy (CT)
|
Van Praagh-Doreau, I.
|
|
2009
|
18 |
S1 |
p. S64-
1 p.
|
artikel
|
| 41 |
0040 Correlation between bcl-2 expression and prognostic factors of breast cancer
|
Gwak, G.
|
|
2009
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 42 |
0044 Correlation between histoculture drug response assay (HDRA) and HER2/neu&ER expression in women with breast cancer
|
Lee, J.
|
|
2009
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 43 |
0242 Cost effectiveness analysis of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer
|
Hashem, T.
|
|
2009
|
18 |
S1 |
p. S78-
1 p.
|
artikel
|
| 44 |
0064 CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome
|
Schroth, W.
|
|
2009
|
18 |
S1 |
p. S34-
1 p.
|
artikel
|
| 45 |
0224 Cystic hypersecretory carcinoma of the breast
|
Kajo, K.
|
|
2009
|
18 |
S1 |
p. S74-
1 p.
|
artikel
|
| 46 |
0076 Delayed chemotherapy and/or dose reduction. A model to accurately predict the dose-intensity
|
Banu, E.
|
|
2009
|
18 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 47 |
0147 Demographic features and prognostic profiles of adjuvant chemotherapy regimens in Chinese breast cancer patients
|
Yin, W.
|
|
2009
|
18 |
S1 |
p. S56-
1 p.
|
artikel
|
| 48 |
0003 Detection of methylation in the CpG islands of the RASSF1A gene promoter in breast cancer (BC)
|
Desiris, K.A.
|
|
2009
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 49 |
0058 Determination of ASCO recommended prognostic factors uPA/PAI-1 in clinical routine and the node-negative NNBC 3-Europe therapy trial
|
Thomssen, C.
|
|
2009
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 50 |
0006 Development of novel breast cancer stem cell therapy targeting hedgehog signaling pathway
|
Tanaka, H.
|
|
2009
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 51 |
0031 Diabetic mastopathy - a benign breast condition that mimics breast carcinoma
|
Chia, C.S.
|
|
2009
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 52 |
0217 Differences in outcome of young breast cancer patients according to BRCA1 mutation status
|
Gabrys, D.
|
|
2009
|
18 |
S1 |
p. S72-S73
2 p.
|
artikel
|
| 53 |
0188 Distant recurrence and subsequent mortality in breast cancer patients treated at 5 UK centres
|
Doughty, J.C.
|
|
2009
|
18 |
S1 |
p. S66-
1 p.
|
artikel
|
| 54 |
0004 DNA hypermethylation in breast cancer and its association with clinicopathological features
|
Chen, F.
|
|
2009
|
18 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 55 |
0192 Does the stellate ganglion block reduce severe hot flushes and sleep disturbances in breast cancer patients?
|
Haest, K.
|
|
2009
|
18 |
S1 |
p. S67-
1 p.
|
artikel
|
| 56 |
0152 Dose-dense nab-paclitaxel vs paclitaxel with bevacizumab following adriamycin and cytoxan is safe as adjuvant therapy in patients with early-stage breast cancer
|
Pippen, J.
|
|
2009
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 57 |
0160 Dosing of zoledronic acid (ZOL) throughout the treatment continuum in patients (pts) with breast cancer (BC)
|
Hadji, P.
|
|
2009
|
18 |
S1 |
p. S60-
1 p.
|
artikel
|
| 58 |
0103 Ductal breast carcinomas: Residual tumor rate in re-excisions after breast conserving surgery
|
Sancho Pérez, B.
|
|
2009
|
18 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 59 |
0030 Dynamic magnetic resonance imaging predicts biological features of breast cancer
|
Schneider, J.
|
|
2009
|
18 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 60 |
0074 Early prognosis prediction: MammaPrint on core-needle biopsies
|
de Snoo, F.
|
|
2009
|
18 |
S1 |
p. S37-
1 p.
|
artikel
|
| 61 |
0108 Early result: Volume replacement with Polyglatin910 mesh for breast reconstruction after endoscopic breast conservative surgery of early breast cancer
|
Shin, H.
|
|
2009
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 62 |
0149 Echocardiography is better than MUGA scan in some breast cancer patients to monitor LVEF for adjuvant trastuzumab therapy
|
Moe, M.M.
|
|
2009
|
18 |
S1 |
p. S56-S57
2 p.
|
artikel
|
| 63 |
Editorial Board
|
|
|
2009
|
18 |
S1 |
p. iii-
1 p.
|
artikel
|
| 64 |
0013 Effect of RNA interference mediated inhibition of VASP expression level on migration and invasion of human mammary epithelial tumor cells
|
Han, G.
|
|
2009
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 65 |
0033 Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women by baseline estradiol levels
|
Powles, T.
|
|
2009
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 66 |
0042 EGFR expression and dimerization in the breast cancer resected postoperation tissue can be a negative prognostic factor
|
Garmanchouk, L.V.
|
|
2009
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 67 |
0068 Elevated bone resorption predicts shorter recurrence-free survival (RFS) for bone metastasis in breast cancer (BC)
|
Lipton, A.
|
|
2009
|
18 |
S1 |
p. S35-
1 p.
|
artikel
|
| 68 |
0005 Epigallocatechin-3-gallate decreases VASP expression and MCF-7 cells invasion by inhibiting Rac1 activity
|
Zhang, Y.
|
|
2009
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 69 |
0008 Epigenetic field cancerization of MTHFR gene in breast carcinomas
|
Lee, J.
|
|
2009
|
18 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 70 |
0203 Evaluating the needs of women living with metastatic breast cancer: A global survey
|
Mayer, M.
|
|
2009
|
18 |
S1 |
p. S70-
1 p.
|
artikel
|
| 71 |
0114 Evaluation of the impact of postmastectomy adjuvant radiotherapy in patients with less than four axillary lymph nodes: A retrospective analysis
|
Gangopadhyay, A.
|
|
2009
|
18 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 72 |
0201 Evidence-based recommendation for discussing complementary and alternative therapy use with cancer patients
|
Schofield, P.E.
|
|
2009
|
18 |
S1 |
p. S69-S70
2 p.
|
artikel
|
| 73 |
0043 Expression of a multidrug resistance gene product p170 glycoprotein in neoplastic breast tissues
|
Gennatas, C.
|
|
2009
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 74 |
0017 Expression of beclin-1 in breast cancer
|
Song, J.
|
|
2009
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 75 |
0050 Expression of ER, p53 and HER-2/neu in medullary carcinoma and infiltrating ductal carcinoma with medullary feature
|
Kim, S.
|
|
2009
|
18 |
S1 |
p. S30-
1 p.
|
artikel
|
| 76 |
0046 Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors
|
Motomura, K.
|
|
2009
|
18 |
S1 |
p. S29-
1 p.
|
artikel
|
| 77 |
0067 Factors influencing postoperative chemotherapy of elderly breast cancer patients
|
Ma, C.
|
|
2009
|
18 |
S1 |
p. S35-
1 p.
|
artikel
|
| 78 |
0202 Fatigue in early breast cancer patients receiving adjuvant postoperative chemotherapy
|
Heras, P.
|
|
2009
|
18 |
S1 |
p. S70-
1 p.
|
artikel
|
| 79 |
0142 Feasibility study of fluorouracil/epirubicin/cyclophosphamide (FEC75) followed by docetaxel (DOC) as adjuvant chemotherapy in Japanese patients with node positive breast cancer
|
Rai, Y.
|
|
2009
|
18 |
S1 |
p. S54-
1 p.
|
artikel
|
| 80 |
0143 First efficacy report for China TAX 619 study: Docetaxel in combination with anthracycline and cyclophosphamide or docetaxel followed by anthracycline and cyclophosphamide in adjuvant therapy for operable node positive breast cancer
|
Shen, Z.
|
|
2009
|
18 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 81 |
0145 First safety data from a randomised phase III trial comparing adjuvant epirubicin–cyclophosphamide → docetaxel (EC → T) vs ET → capecitabine (X) in N+ operable breast cancer (BC)
|
Martín, M.
|
|
2009
|
18 |
S1 |
p. S55-
1 p.
|
artikel
|
| 82 |
0157 GAIN study: A phase III trial to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancer
|
von Minckwitz, G.
|
|
2009
|
18 |
S1 |
p. S59-
1 p.
|
artikel
|
| 83 |
0041 HER-2 codon 655 single nucleotide polymorphism and HER-2 protein expression in ductal breast cancer
|
Zubor, P.
|
|
2009
|
18 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 84 |
0185 High-dose fulvestrant (500 mg): Clinical evidence supporting potentially improved efficacy benefits in hormone receptor-positive (HR+) advanced breast cancer (ABC)
|
Harbeck, N.
|
|
2009
|
18 |
S1 |
p. S65-
1 p.
|
artikel
|
| 85 |
0070 Hormone receptors and HER2 status can change in recurrent breast cancer
|
Eppenberger-Castori, S.
|
|
2009
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 86 |
0024 How does the method of diagnosis influence the margin status of resection in breast conserving surgery of ductal carcinomas?
|
Sancho Pérez, B.
|
|
2009
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 87 |
0113 Hypofractionated adjuvant radiotherapy for early breast cancer: A prospective randomized study
|
Saha, S.
|
|
2009
|
18 |
S1 |
p. S47-
1 p.
|
artikel
|
| 88 |
0155 ICE study: Ibandronate with or without capecitabine in elderly patients with early breast cancer
|
Reimer, T.
|
|
2009
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 89 |
0234 Impact of education level on clinical characteristics of breast cancer at diagnosis in China
|
Gao, J.
|
|
2009
|
18 |
S1 |
p. S77-
1 p.
|
artikel
|
| 90 |
0007 Importance of estrogen metabolites (2-OH/16a-OH) in the pathogenesis of breast, ovarian and endometrial cancer in postmenopausal women
|
Antonova, I.B.
|
|
2009
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 91 |
0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population
|
Howell, A.
|
|
2009
|
18 |
S1 |
p. S51-
1 p.
|
artikel
|
| 92 |
0028 Intraoperative imprint cytology for the evaluation of lumpectomy margins status in patients undergoing conservative surgery for early breast cancer
|
Salemis, N.S.
|
|
2009
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 93 |
0116 Intra-operative radiotherapy for breast cancer in patients where external beam radiation was not possible - results after 3 years of follow-up
|
Keshtgar, M.
|
|
2009
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 94 |
0115 Intraoperative radiotherapy in early breast cancer - preliminary experience
|
Steiner, M.
|
|
2009
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 95 |
0083 Intra-operative sentinel node metastasis detection in breast cancer by one-step nucleic acid amplification (OSNA): From validation to routine use
|
Khaddage, A.
|
|
2009
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 96 |
0101 Is BCS always successful?
|
Yoon, C.S.
|
|
2009
|
18 |
S1 |
p. S44-
1 p.
|
artikel
|
| 97 |
0089 Isolated tumor cells in the sentinel lymph node in breast cancer: Only a dimensional difference from micrometastases?
|
Giorgetta, C.E.
|
|
2009
|
18 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 98 |
0102 Isotope-guided surgery for non-palpable breast cancer in Chinese women
|
Hung, W.K.
|
|
2009
|
18 |
S1 |
p. S44-
1 p.
|
artikel
|
| 99 |
0085 Is sentinel lymph node biopsy truly reliable as a single predictor for lymph node metastasis?
|
Ko, B.
|
|
2009
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 100 |
0097 Is skin-sparing mastectomy oncologically safe also in T3 breast cancer?
|
Lim, W.
|
|
2009
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 101 |
0104 Is surgical excision necessary for benign phyllodes tumor of the breast diagnosed and excised by ultrasound-guided vacuum assisted biopsy device (Mammotome)?
|
Park, H.
|
|
2009
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 102 |
0105 Is there a promotion of metastasis by autologeous breast reconstruction in patients with invasive breast cancer?
|
Smeets, A.
|
|
2009
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 103 |
0161 Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Update of the BIG 1-98 primary core analysis
|
Thürlimann, B.
|
|
2009
|
18 |
S1 |
p. S60-
1 p.
|
artikel
|
| 104 |
0221 Locally advanced breast cancer in Asian women
|
Lee, J.
|
|
2009
|
18 |
S1 |
p. S73-S74
2 p.
|
artikel
|
| 105 |
0053 Local recurrence rates after breast conserving surgery according to age, location, ER, PR and HER status
|
Ostapenko, V.
|
|
2009
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 106 |
0232 Male breast cancer in Tripoli/Libya
|
Elhabbash, M.M.
|
|
2009
|
18 |
S1 |
p. S76-
1 p.
|
artikel
|
| 107 |
0231 Male patients treated for breast cancer at the institute for oncology and radiology of Serbia in 2001-2002
|
Posarac, V.
|
|
2009
|
18 |
S1 |
p. S76-
1 p.
|
artikel
|
| 108 |
0194 Medical ozone oil suspension applications heal osteonecrosis of the jaws (ONJS) in patients treated with bisfosfonates (BPS). Preliminary results of a single institution protocol
|
Ripamonti, C.
|
|
2009
|
18 |
S1 |
p. S67-S68
2 p.
|
artikel
|
| 109 |
0027 Misdiagnosis for intraoperative touch imprint cytology (TIC) of sentinel lymph node for early-stage invasive breast cancer: What affects the overall accuracy of TIC?
|
Chen, J.
|
|
2009
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 110 |
0198 Morbidities after local/regional treatment of breast cancer and patients' quality of life
|
Ozcinar, B.
|
|
2009
|
18 |
S1 |
p. S69-
1 p.
|
artikel
|
| 111 |
0158 Multicenter prospective study of bone effects on anastrozole in Japanese postmenopausal patients with breast cancer - results of one year follow-up (SBCCSG 06;UMIN 514)
|
Futsuhara, K.
|
|
2009
|
18 |
S1 |
p. S59-
1 p.
|
artikel
|
| 112 |
0228 Multicentre investigation of HER2 expression in 1806 infiltrating carcinomas of the breast in the Chinese population
|
Lu, Z.
|
|
2009
|
18 |
S1 |
p. S75-S76
2 p.
|
artikel
|
| 113 |
0195 Multidisciplinary service coordinator and clinical care nurse - an intertwined model of multidisciplinary care
|
Museth, K.E.
|
|
2009
|
18 |
S1 |
p. S68-
1 p.
|
artikel
|
| 114 |
0230 Multiple primary neoplasms on breast cancer survivors
|
Lukavetskyy, N.
|
|
2009
|
18 |
S1 |
p. S76-
1 p.
|
artikel
|
| 115 |
0172 Neoadjuvant gemcitabine plus doxorubicin (G+A) versus FAC regimen for locally advanced breast cancer patients (phase III randomized study)
|
El-Zawahry, H.M.
|
|
2009
|
18 |
S1 |
p. S61-
1 p.
|
artikel
|
| 116 |
0171 Neoadjuvant TAC for locally advanced breast cancer: Correlation between response and biological features
|
Giardina, G.P.
|
|
2009
|
18 |
S1 |
p. S61-
1 p.
|
artikel
|
| 117 |
0100 Nipple–areola-sparing mastectomy: Over 10 years follow-up
|
Umemura, T.
|
|
2009
|
18 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 118 |
0099 Nipple sparing mastectomy: Nipple–areolar recurrence
|
Seo, J.
|
|
2009
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 119 |
0156 Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial
|
Gnant, M.
|
|
2009
|
18 |
S1 |
p. S59-
1 p.
|
artikel
|
| 120 |
0059 Oncotype Dx, St. Gallen risk group and Adjuvantlonline nomogram as prognostic predictor
|
Leitzin, L.
|
|
2009
|
18 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 121 |
0093 One step nucleic acid amplification (OSNA) as a diagnostic tool for the detection of lymph node metastases in breast cancer patients: From postoperative performance evaluation to intra-operative routine use
|
Schem, C.
|
|
2009
|
18 |
S1 |
p. S42-
1 p.
|
artikel
|
| 122 |
0107 Outcomes of immediate reconstruction with absorbable polypropylene mesh in breast conserving surgery for early breast cancer
|
Yom, C.
|
|
2009
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 123 |
0197 Palonosetron (PALO) plus dexamethasone (DEX) administered on day only prevents emesis and avoids prolonged DEX use in breast cancer patients treated with anthracycline/cyclophosphamide regimens
|
Aapro, M.
|
|
2009
|
18 |
S1 |
p. S68-
1 p.
|
artikel
|
| 124 |
0015 PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines
|
Liu, Z.
|
|
2009
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 125 |
0009 Peroxisome proliferator-activated receptor (PPAR)-gamma ligand enhances the growth inhibitory activity of tamoxifen in MCF-7 cells
|
Youn, H.
|
|
2009
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 126 |
0170 Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): A multi-centre study from British Columbia
|
Chia, S.
|
|
2009
|
18 |
S1 |
p. S61-
1 p.
|
artikel
|
| 127 |
0065 Predictive factors for response to fulvestrant - the impact of prior endocrine response on treatment outcome
|
Gradishar, W.
|
|
2009
|
18 |
S1 |
p. S34-
1 p.
|
artikel
|
| 128 |
0173 Predictive value of 18F-FDG PET-CT in primary breast cancer patients receiving neoadjuvant chemotherapy
|
Tsang, J.W.H.
|
|
2009
|
18 |
S1 |
p. S61-S62
2 p.
|
artikel
|
| 129 |
0012 Presence of an in-situ component is associated with reduced biological aggressiveness of invasive breast cancer as assessed by Ki-67 indices
|
Wong, H.
|
|
2009
|
18 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 130 |
0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results
|
Semiglazov, V.F.
|
|
2009
|
18 |
S1 |
p. S63-
1 p.
|
artikel
|
| 131 |
0181 PROACT: A randomised study comparing anastrozole with tamoxifen as neoadjuvant and adjuvant treatment in postmenopausal women with locally advanced breast cancer - a Japanese subgroup analysis
|
Imoto, S.
|
|
2009
|
18 |
S1 |
p. S64-
1 p.
|
artikel
|
| 132 |
0227 Profile of in situ carcinoma of the breast in our hospital
|
Carrascal, A.
|
|
2009
|
18 |
S1 |
p. S75-
1 p.
|
artikel
|
| 133 |
0062 Prognostic factors for breast cancer - clinical testing and validation from archival material
|
Jaggi, R.
|
|
2009
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 134 |
0061 Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
|
Tamura, N.
|
|
2009
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 135 |
0069 Prognostic factors upa and PAI-1: Feasibility and validity of determination in clinical routine
|
Vetter, M.
|
|
2009
|
18 |
S1 |
p. S35-
1 p.
|
artikel
|
| 136 |
0048 Prognostic value of gene expression of ASAH1, LASS4 and LASS6 in breast cancer
|
Ruckhäberle, E.
|
|
2009
|
18 |
S1 |
p. S29-
1 p.
|
artikel
|
| 137 |
Program Overview
|
|
|
2009
|
18 |
S1 |
p. xiii-
1 p.
|
artikel
|
| 138 |
0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)
|
Wildiers, H.
|
|
2009
|
18 |
S1 |
p. S64-S65
2 p.
|
artikel
|
| 139 |
0112 Prone versus supine breast irradiation in early stage breast cancer patients
|
Trela, K.
|
|
2009
|
18 |
S1 |
p. S47-
1 p.
|
artikel
|
| 140 |
0191 Protection of ovarian function with an LH-RH analogue during chemotherapy in young breast cancer patients
|
Ogawa, M.
|
|
2009
|
18 |
S1 |
p. S66-S67
2 p.
|
artikel
|
| 141 |
0196 Psychosocial and physical activities in shaping quality of life in breast cancer patients among Indian population
|
Selvan, B.
|
|
2009
|
18 |
S1 |
p. S68-
1 p.
|
artikel
|
| 142 |
0117 Radiofrequency ablation of early breast cancer followed by delayed surgical resection
|
Ohtani, S.
|
|
2009
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 143 |
0148 REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients
|
von Minckwitz, G.
|
|
2009
|
18 |
S1 |
p. S56-
1 p.
|
artikel
|
| 144 |
0226 Report of Cowden's syndrome in patient with PTEN mutation
|
Melbarde-Gorkusa, I.
|
|
2009
|
18 |
S1 |
p. S75-
1 p.
|
artikel
|
| 145 |
0178 Results of clinical endpoints of a randomized phase II trial with doxorubicin + pemetrexed followed by docetaxel versus doxorubicin + cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer
|
Schneeweiss, A.
|
|
2009
|
18 |
S1 |
p. S63-
1 p.
|
artikel
|
| 146 |
0210 Retrospective analysis of clinico-pathological trends of triple negative breast cancer: Experience from a tertiary care center of South India
|
Jain, A.
|
|
2009
|
18 |
S1 |
p. S71-
1 p.
|
artikel
|
| 147 |
0140 Retrospective study for pegylated liposomal doxorubicin in adjuvant breast cancer therapy
|
Lu, Y.
|
|
2009
|
18 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 148 |
0153 Routine clinical usage of trastuzumab (Herceptin®) in the adjuvant treatment of breast cancer in Germany - a prospective registry study
|
Dall, P.
|
|
2009
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 149 |
0190 Réseau Romand Fertilité et Cancer (RRFC): Feasibility assessment of a fertility preservation program for young women with early stage breast cancer (EBC)
|
Zaman, K.
|
|
2009
|
18 |
S1 |
p. S66-
1 p.
|
artikel
|
| 150 |
S35 Adjuvant therapies for premenopausal women with endocrine-responsive disease
|
Davidson, N.E.
|
|
2009
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 151 |
S42 Adjuvant therapy of triple negative breast cancer
|
Perez, E.A.
|
|
2009
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 152 |
S5 Aiming at the target: In the crosshairs or the crossfire?
|
Piccart-Gebhart, M.
|
|
2009
|
18 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 153 |
S29 Axillary sentinel lymph node: How low can you go?
|
Galimberti, V.
|
|
2009
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 154 |
S17 Breast cancer stem cells: Getting to treat the core
|
Wicha, M.S.
|
|
2009
|
18 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 155 |
S28 Breast conservation and clear margins: Invasive or in situ involvement
|
Morrow, M.
|
|
2009
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 156 |
S27 Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy
|
Veronesi, P.
|
|
2009
|
18 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 157 |
S26 Breast conservation in the very young
|
Rutgers, E.
|
|
2009
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 158 |
0241 Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patients
|
Retel, V.P.
|
|
2009
|
18 |
S1 |
p. S78-
1 p.
|
artikel
|
| 159 |
S10 Chemoprevention of breast cancer for mutation carriers and other high risk women
|
Decensi, A.
|
|
2009
|
18 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 160 |
Scientific Program Friday, 13 March 2009
|
|
|
2009
|
18 |
S1 |
p. xvii-
1 p.
|
artikel
|
| 161 |
Scientific Program Saturday, 14 March 2009
|
|
|
2009
|
18 |
S1 |
p. xviii-
1 p.
|
artikel
|
| 162 |
Scientific Program Thursday, 12 March 2009
|
|
|
2009
|
18 |
S1 |
p. xvi-
1 p.
|
artikel
|
| 163 |
Scientific Program Wednesday, 11 March 2009
|
|
|
2009
|
18 |
S1 |
p. xv-
1 p.
|
artikel
|
| 164 |
S20 Combined ER and HER-targeted therapy in breast cancer treatment
|
Osborne, K.
|
|
2009
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 165 |
S9 Current knowledge on genetic predispositions for breast cancer
|
Brody, L.C.
|
|
2009
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 166 |
S4 Did we learn more about adjuvant chemotherapy? The dark side of data from clinical trials
|
Oakman, C.
|
|
2009
|
18 |
S1 |
p. S2-
1 p.
|
artikel
|
| 167 |
S7 EGFR and HER2: Systemic approaches to oncogenic networks and to pharmaceutical perturbations
|
Yarden, Y.
|
|
2009
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 168 |
0086 Selective axillary lymph node dissection differs from the arm lymph flow shown by 3D-CT lymphography
|
Yamashita, K.
|
|
2009
|
18 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 169 |
0084 Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients; single institutional experience
|
Kim, J.
|
|
2009
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 170 |
0082 Sentinel lymph node biopsy for breast cancer: How many nodes to stop at? Our experience at a tertiary centre in Singapore
|
Pang, J.S.Y.
|
|
2009
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 171 |
0176 Sentinel lymph node biopsy for patients with breast cancer treated with neoadjuvant chemotherapy
|
Shimazu, K.
|
|
2009
|
18 |
S1 |
p. S62-
1 p.
|
artikel
|
| 172 |
0091 Sentinel node biopsy after previous breast surgery: Increasing evidence
|
Burgoa, L.
|
|
2009
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 173 |
0080 Sentinel node biopsy in DCIS patients: Is it recommended and in whom?
|
Mentrak, Z.
|
|
2009
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 174 |
0144 Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with breast cancer with 4 or more positive lymph nodes
|
Boy, D.
|
|
2009
|
18 |
S1 |
p. S55-
1 p.
|
artikel
|
| 175 |
0051 Serum VEGF-C and serum VEGF-R2 in patients with triple negative breast cancer
|
Iosifidou, R.
|
|
2009
|
18 |
S1 |
p. S30-
1 p.
|
artikel
|
| 176 |
S1 Facilitating consensus by examining patterns of treatment effects
|
Gelber, R.D.
|
|
2009
|
18 |
S1 |
p. S1-
1 p.
|
artikel
|
| 177 |
S12 Five year results of a randomised placebo controlled trial of lasofoxifene (PEARL) on the incidence of ER positive breast cancer in postmenopausal women with osteoporosis
|
Powles, T.
|
|
2009
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 178 |
0095 Significance of non-SLN removed simultaneously in SLNB for patients with breast cancer
|
Kubo, M.
|
|
2009
|
18 |
S1 |
p. S42-
1 p.
|
artikel
|
| 179 |
S16 Immunizing against breast cancer: A new swing for an old sword
|
Curigliano, G.
|
|
2009
|
18 |
S1 |
p. S7-
1 p.
|
artikel
|
| 180 |
S11 Implications of inherited predisposition for surveillance, risk reduction and treatment
|
Garber, J.E.
|
|
2009
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 181 |
S32 Innovations in radiation therapy (RT) for breast cancer
|
Harris, J.
|
|
2009
|
18 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 182 |
S31 Integrated breast conservation and intraoperative radiation therapy (IORT)
|
Orecchia, R.
|
|
2009
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 183 |
S8 Integrating molecular profiling, histologic type and other variables: Defining the fingerprint of responsiveness to treatment
|
Viale, G.
|
|
2009
|
18 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 184 |
S37 Is there a standard type and duration of adjuvant chemotherapy?
|
Hayes, D.
|
|
2009
|
18 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 185 |
0052 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
|
Lin, Y.
|
|
2009
|
18 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 186 |
S38 Late effects of systemic adjuvant therapies in women diagnosed with breast cancer at a young age
|
Burstein, H.J.
|
|
2009
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 187 |
S36 Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting
|
Colleoni, M.
|
|
2009
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 188 |
S6 Mining the steroid receptor cistrome for novel targets, biomarkers and risk alleles
|
Brown, M.
|
|
2009
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 189 |
S14 Modulation of angiogenesis: Clinical impact (in breast cancer)
|
Kerbel, R.S.
|
|
2009
|
18 |
S1 |
p. S6-
1 p.
|
artikel
|
| 190 |
S21 Molecular imaging of breast cancer
|
de Vries, E.
|
|
2009
|
18 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 191 |
S2 New hypotheses and opportunities: Endocrine therapies
|
Jordan, C.V.
|
|
2009
|
18 |
S1 |
p. S1-
1 p.
|
artikel
|
| 192 |
0111 Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiotherapy - a randomized study
|
Lundstedt, D.
|
|
2009
|
18 |
S1 |
p. S46-S47
2 p.
|
artikel
|
| 193 |
S18 Pharmacogenetics to drive breast cancer treatments
|
McLeod, H.L.
|
|
2009
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 194 |
S33 Radiotherapy of the regional lymph nodes: Shooting at the sheriff?
|
Kunkler, I.
|
|
2009
|
18 |
S1 |
p. S14-
1 p.
|
artikel
|
| 195 |
S19 Regulation of breast cancer metastasis by endogenous human microRNAs
|
Tavazoie, S.
|
|
2009
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 196 |
S43 Review of new targeted drugs: Crawling towards the adjuvant setting
|
Baselga, J.
|
|
2009
|
18 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 197 |
S40 Should genomic profiles be used to determine who should receive adjuvant chemotherapy?
|
Albain, K.S.
|
|
2009
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 198 |
S30 Should the use of contralateral prophylactic mastectomy be increasing as it is?
|
Wood, W.C.
|
|
2009
|
18 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 199 |
S41 Targeting HER2 in the adjuvant setting: Dealing with new standards and open questions
|
Smith, I.E.
|
|
2009
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 200 |
S34 Targeting the tumour and sparing normal tissue: The concept behind the evolution
|
Veronesi, U.
|
|
2009
|
18 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 201 |
S13 The biological information obtainable from circulating tumor cells
|
Cristofanilli, M.
|
|
2009
|
18 |
S1 |
p. S6-
1 p.
|
artikel
|
| 202 |
S3 The changes in breast cancer incidence: A result of recent changes in hormone use by postmenopausal women?
|
Ravdin, P.M.
|
|
2009
|
18 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 203 |
S22 The follow-up of women at high risk for breast cancer relapse
|
Smith, I.E.
|
|
2009
|
18 |
S1 |
p. S9-
1 p.
|
artikel
|
| 204 |
S15 The (last?) word about biomarkers for angiogenesis
|
Bertolini, F.
|
|
2009
|
18 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 205 |
S39 Treatment of postmenopausal women with hormone responsive breast cancer
|
Winer, E.
|
|
2009
|
18 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 206 |
S23 Update of the BIG 1-98 Trial: Where do we stand? Sequential treatment analysis and monotherapy arm analysis
|
Thürlimann, B.
|
|
2009
|
18 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 207 |
S24 Update of the FINHER trial based on 5 years of follow-up
|
Joensuu, H.
|
|
2009
|
18 |
S1 |
p. S10-
1 p.
|
artikel
|
| 208 |
S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer
|
Gianni, L.
|
|
2009
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 209 |
0220 Survival in patients with hereditary breast cancer
|
Boroday, N.V.
|
|
2009
|
18 |
S1 |
p. S73-
1 p.
|
artikel
|
| 210 |
0131 Survival & safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment: A number needed to treat analysis based on the intergroup exemestane study (IES)
|
Kilburn, L.S.
|
|
2009
|
18 |
S1 |
p. S51-
1 p.
|
artikel
|
| 211 |
0035 Synchrotron x-ray diffraction of human hair for the early detection of breast pathologies - preliminary results
|
Polizzi, S.
|
|
2009
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 212 |
0066 Tailored adjuvant therapy for young women with breast cancer
|
Yoshida, M.
|
|
2009
|
18 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 213 |
0204 Targets and sources of the psychological help for breast cancer patients
|
Malova, J.V.
|
|
2009
|
18 |
S1 |
p. S70-
1 p.
|
artikel
|
| 214 |
0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer
|
Moy, B.
|
|
2009
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 215 |
0216 Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer patients
|
Marinopoulos, S.
|
|
2009
|
18 |
S1 |
p. S72-
1 p.
|
artikel
|
| 216 |
0023 The analysis of residual lesion after excision of breast lesion using ultrasound-guided vacuum-assisted biopsy device (Mammotome®)
|
Kim, S.
|
|
2009
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 217 |
0175 The changes of the histologic and biologic markers after neoadjuvant chemotherapy in breast cancer
|
Lee, K.M.
|
|
2009
|
18 |
S1 |
p. S62-
1 p.
|
artikel
|
| 218 |
0246 The changing fashion of breast cancer therapeutics: Analysis of the clinical trial database
|
Kwok, S.S.L.
|
|
2009
|
18 |
S1 |
p. S79-
1 p.
|
artikel
|
| 219 |
0211 The clinical features and prognosis of triple negative breast cancer
|
Izquierdo Sanz, M.
|
|
2009
|
18 |
S1 |
p. S71-
1 p.
|
artikel
|
| 220 |
0016 The coamplification pattern of HER-2/NEU amplicon by real-time PCR in human breast cancer and its clinical significance
|
Lim, W.
|
|
2009
|
18 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 221 |
0021 The discrepancy between results of HER2 receptors in needle biopsy and surgical specimen of breast cancer
|
Sikorsky, N.
|
|
2009
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 222 |
0132 The effect of zoledronic acid in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant letrozole: 24 months integrated follow-up of the Z-FAST/ZO-FAST trials
|
Frassoldati, A.
|
|
2009
|
18 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 223 |
0029 The effects of preoperative 18F-FDG-PET/CT in breast cancer patients in comparison with conventional imaging study
|
Choi, Y.
|
|
2009
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 224 |
0087 The follow-up results of patients without axillary lymph node dissection after false negative SLN biopsy
|
Ko, B.
|
|
2009
|
18 |
S1 |
p. S40-
1 p.
|
artikel
|
| 225 |
0071 The 70-gene MammaPrint profile allows to identify a subgroup of very good-prognostic patients with primary breast cancer and 4-9 positive lymph nodes
|
Saghatchian, M.
|
|
2009
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 226 |
0072 The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancer
|
Knauer, M.
|
|
2009
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 227 |
0073 The 70-gene MammaPrint signature is predictive for chemotherapy benefit in early breast cancer
|
Knauer, M.
|
|
2009
|
18 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 228 |
0199 The impact of adjuvant chemotherapy on quality of life in women with early breast cancer
|
Bulotiene, G.
|
|
2009
|
18 |
S1 |
p. S69-
1 p.
|
artikel
|
| 229 |
0200 The impact of culture, sociological and psychological issues on Muslim breast cancer patients in Pakistan
|
Banning, M.
|
|
2009
|
18 |
S1 |
p. S69-
1 p.
|
artikel
|
| 230 |
0057 The impact of the ratio of positive nodes to removed nodes on recurrence and overall survival in node positive breast cancer patients
|
Lee, S.
|
|
2009
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 231 |
0193 The impact of type of surgery on quality of life in elderly women with breast cancer
|
Noguero Meseguer, M.
|
|
2009
|
18 |
S1 |
p. S67-
1 p.
|
artikel
|
| 232 |
0106 The management of the contralateral breast in breast reconstruction in Korean females
|
Jung, J.
|
|
2009
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 233 |
0136 The number needed to treat to save a life: A comparison between aromatase inhibitors
|
Rugo, H.S.
|
|
2009
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 234 |
0235 The pattern of breast cancer among patients with the HIV/AIDS virus in Uganda - Kampala
|
Mbabazi, M.
|
|
2009
|
18 |
S1 |
p. S77-
1 p.
|
artikel
|
| 235 |
0233 The risk of breast cancer among women who start smoking as teenagers
|
Odiase, E.
|
|
2009
|
18 |
S1 |
p. S77-
1 p.
|
artikel
|
| 236 |
0150 The severity of chemotherapy-induced neutropenia in association with PTGS-2 gene polymorphism in breast cancer patients
|
Yeo, W.
|
|
2009
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 237 |
0045 The significance of annexin A1 expression in breast cancer
|
Yom, C.
|
|
2009
|
18 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 238 |
0056 The simplest model for prediction of nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes
|
Kim, K.
|
|
2009
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 239 |
0098 The timing of recurrence after the surgery of breast cancer
|
Jung, J.
|
|
2009
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 240 |
0001 Thymidylate synthase: Tumor promoter and oncogene in sporadic breast tumorigenesis?
|
Barclay, B.
|
|
2009
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 241 |
0110 Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy
|
Karlsson, P.
|
|
2009
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 242 |
0186 Treatment options for locally advanced or metastatic triple negative breast cancer: A survey of current UK practice
|
Kilburn, L.S.
|
|
2009
|
18 |
S1 |
p. S65-
1 p.
|
artikel
|
| 243 |
0243 Trends of adjuvant systemic therapy of breast cancer in Grodno region (Belarus)
|
Kazakevich, D.
|
|
2009
|
18 |
S1 |
p. S78-S79
2 p.
|
artikel
|
| 244 |
0212 Triple negative breast cancer - a retrospective analysis
|
Shklar, Z.
|
|
2009
|
18 |
S1 |
p. S71-
1 p.
|
artikel
|
| 245 |
0214 Triple negative breast cancer: Long-term prognosis and treatment target on molecular biological characteristics
|
Aogi, K.
|
|
2009
|
18 |
S1 |
p. S72-
1 p.
|
artikel
|
| 246 |
0010 Tryptase expression correlates to angiogenesis in early breast cancer
|
Mininni, M.
|
|
2009
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 247 |
0054 Tumor size rather than c-erbB-2 gene amplification significantly influence the disease outcome in postmenopausal steroid receptor-positive breast cancer patients treated with adjuvant tamoxifen
|
Susnjar, S.
|
|
2009
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 248 |
0022 Ultrasound-guided Mammotome® biopsy for breast microcalcification using 2-dimensional mammography localization
|
Yom, C.
|
|
2009
|
18 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 249 |
0096 Usefulness of intraoperative histologic assessment of surgical margins
|
Kikuyama, M.
|
|
2009
|
18 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 250 |
0075 Use of the genomic test MammaPrint in daily clinical practice to assist in risk stratification of young breast cancer patients
|
Kunz, G.
|
|
2009
|
18 |
S1 |
p. S37-
1 p.
|
artikel
|
| 251 |
0047 Validation of the prognostic impact of Ep-CAM in untreated node-negative breast cancer
|
Schmidt, M.
|
|
2009
|
18 |
S1 |
p. S29-
1 p.
|
artikel
|
| 252 |
0081 Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma
|
Park, E.H.
|
|
2009
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 253 |
0240 Variation in early breast cancer adjuvant therapy practice among UK oncologists
|
Moe, M.M.
|
|
2009
|
18 |
S1 |
p. S78-
1 p.
|
artikel
|
| 254 |
0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group
|
Zagouri, F.
|
|
2009
|
18 |
S1 |
p. S66-
1 p.
|
artikel
|
| 255 |
0179 Weekly paclitaxel and carboplatin is an effective non-anthracycline regimen in preoperative therapy of breast cancer
|
Chen, X.
|
|
2009
|
18 |
S1 |
p. S63-
1 p.
|
artikel
|
| 256 |
0180 Weekly paclitaxel plus carboplatin +/− trastuzumab in preoperative therapy of Her2-neu over-expressing breast cancer: A pilot phase II study
|
Chen, X.
|
|
2009
|
18 |
S1 |
p. S63-S64
2 p.
|
artikel
|
| 257 |
0088 What is the profile of patients with breast cancer undergoing sentinel node biopsy in our hospital?
|
Blanco Guerrero, M.
|
|
2009
|
18 |
S1 |
p. S40-
1 p.
|
artikel
|
| 258 |
0229 When do locoregional recurrencies occur and how common is contralateral breast cancer?
|
Sundquist, M.
|
|
2009
|
18 |
S1 |
p. S76-
1 p.
|
artikel
|
| 259 |
0139 Why 28% of ER-negative/PR-negative breast cancer (BC) patients did not get chemotherapy (CT)
|
Brouckaert, O.
|
|
2009
|
18 |
S1 |
p. S53-
1 p.
|
artikel
|
| 260 |
0159 Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozole
|
Safra, T.
|
|
2009
|
18 |
S1 |
p. S60-
1 p.
|
artikel
|
Tijdschrift beschrijving